指南与共识外周血管介入DSA

ACC/AHA/SCAI/SIR/SVM 2018年外周动脉介入适当使用标准:美国心脏病学会适当使用标准工作组、美国心脏协会、心血管造影与介入学会、介入放射学会和血管医学会报告

ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine.
指南 / 共识 · J Am Coll Cardiol · 2018-12-17

美国心脏病学会联合多家学会制定首个多学会外周动脉介入适当使用标准,基于已发表指南、试验数据和专家意见构建45个临床场景,由独立评分小组按1–9分评为适当、可能适当或很少适当,强调先充分药物治疗,在组织缺损或终末器官受损时血管内与外科再血管化均属适当。

要点

  • 评分7–9分为适当,4–6分为可能适当,1–3分为很少适当。
  • 在合并组织缺损或终末器官受损的场景中,血管内与外科再血管化均评为适当。
  • 这些场景中倾向选择血管内方式,尤其膝下解剖分布及既往接受过血管内或外科再血管化者。

核心结论

  • 本适当使用标准旨在为转诊再血管化治疗的临床医生以及介入医生和外科医生提供指导。
  • 在希望症状管理或偶然发现病变的情况下,强调遵循并充分药物治疗以获得最大获益。
  • 当药物治疗不足时,需确定合适的再血管化策略。

研究设计与样本

  • 由美国心脏病学会与美国心脏协会、心血管造影与介入学会、介入放射学会和血管医学会等多个学会合作制定适当使用标准。
  • 场景依据已发表指南、试验数据和外周动脉疾病领域专家意见创建。
  • 写作组制定45个临床场景,每个场景最多6种介入选项,归入6个一般部分。
  • 由独立的评分小组按1至9分评分量表对每个适应证进行评估。

诊断标准与关键数值

  • 评分7至9分指定为「适当」。
  • 评分4至6分指定为「可能适当」。
  • 评分1至3分指定为「很少适当」。
  • 在合并组织缺损或终末器官受损的临床场景中,评分小组判定血管内和外科两种方式均属适当。
  • 这些场景中倾向选择血管内方式,尤其在膝下解剖分布及既往接受过血管内或外科再血管化的情况下。

临床应用与阅片要点

  • 在希望症状管理或偶然发现病变时,强调遵循并充分药物治疗以获得最大获益。
  • 当药物治疗不足时,需确定合适的再血管化策略。
  • 考虑症状负担、解剖分布和缺血负担等因素后进行评分判定。
  • 写作组认为有必要涉及为促进其他操作(如经皮瓣膜置换或血流动力学支持)而可能需要辅助动脉再血管化的情况,这些临床情况常使血管内介入更具吸引力并反映在评分中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The American College of Cardiology (ACC) collaborated with the American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine, along with several ACC Councils, to establish and evaluate Appropriate Use Criteria (AUC) for peripheral artery intervention (PAI). Although PAI has been the subject of prior single-society papers, this is the first multisocietal effort on the topic. To initiate the AUC process, patient scenarios that are common in clinical practice were drafted, along with assumptions and definitions for those scenarios. The scenarios were created using published guidelines, trial data, and expert opinions from within the field of peripheral artery disease. The writing group developed 45 clinical scenarios with up to 6 intervention options per scenario and categorized them into 6 general sections. A separate, independent rating panel evaluated each indication using a scoring scale from 1 to 9, thereby designating each indication as “Appropriate” (score of 7 to 9), “May Be Appropriate” (score of 4 to 6), or “Rarely Appropriate” (score of 1 to 3). Throughout the scenarios, emphasis was placed on adhering to and exhausting medical therapy to achieve maximal benefit in those situations in which symptom management was desired or incidental disease was discovered. However, situations arise in which medical therapy is insufficient, and identifying a suitable revascularization strategy is necessary. After considering factors such as symptom burden, anatomic distribution, and ischemic burden, the rating panel determined that both endovascular and surgical approaches are Appropriate in clinical scenarios involving concomitant tissue loss or end organ compromise. There was a tendency to select endovascular approaches in these scenarios, particularly in anatomic distributions below the knee and where prior endovascular or surgical revascularization has been performed. Given the dynamic landscape of cardiovascular medicine, the writing group felt it was necessary to address situations in which adjunct arterial revascularization may be necessary to facilitate other procedures such as percutaneous valve replacement or hemodynamic support. The clinical situations where this occurs often make endovascular interventions more attractive and that was reflected in the ratings. The purpose of this particular AUC is to provide guidance to clinicians who may refer patients for revascularization treatments and to interventionalists and surgeons themselves. With the field of peripheral artery disease constantly evolving, it is imperative to offer tools and resources that physicians can utilize to provide the best care for their patients.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Bailey SR, Beckman JA, Dao TD, et al. ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine. J Am Coll Cardiol. 2018. PMID: 30573393. doi:10.1016/j.jacc.2018.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。